MedTrace Logo

Palmitic Acid and Human Microvascular Function

NCT06683534 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-29

No results posted yet for this study

Summary

The goal of this study is to learn how a supplement Quercetin can affect microvascular function.

Participants will:

* give two blood draws of 5 mL each
* have a camera placed under the tongue to take pictures of blood vessels
* have 2 laser Doppler microdialysis catheters placed on the forearm to monitor blood vessels before and after local drug infusion

Researchers will compare blood vessel function of those who take estrogen supplements to those who do not.

Conditions

  • Microvascular Dysfunction
  • Microvasculature
  • Cardiovascular Diseases
  • Cardiovascular Diseases (CVD)
  • Microvascular Health
  • Obesity and Overweight

Interventions

DIETARY_SUPPLEMENT

Quercetin (dietary supplement)

Quercetin will be provided to take one Quercetin per day for 30 days to look for differences in microvascular function.

DRUG

Placebo

Subjects randomized to receive placebo will be administered a standard placebo sugar pill.

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06683534 on ClinicalTrials.gov